BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 17630360)

  • 1. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
    Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of subchronic administration of 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526), a novel acid pump antagonist, on gastric acid secretion and gastrin levels in rats.
    Ito K; Kinoshita K; Tomizawa A; Morikawa-Inomata Y; Inaba F; Fujita Y; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2008 Jul; 326(1):163-70. PubMed ID: 18411413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
    Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y
    J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
    Kinoshita M; Saito N; Noto T; Tamaki H
    J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the gastric H+,K+ -ATPase by plectrinone A, a diterpenoid isolated from Plectranthus barbatus Andrews.
    Schultz C; Bossolani MP; Torres LM; Lima-Landman MT; Lapa AJ; Souccar C
    J Ethnopharmacol; 2007 Apr; 111(1):1-7. PubMed ID: 17166678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers.
    Nishida H; Hasuoka A; Arikawa Y; Kurasawa O; Hirase K; Inatomi N; Hori Y; Sato F; Tarui N; Imanishi A; Kondo M; Takagi T; Kajino M
    Bioorg Med Chem; 2012 Jun; 20(12):3925-38. PubMed ID: 22579619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol e.
    Sohn SK; Chang MS; Choi WS; Kim KB; Woo TW; Lee SB; Chung YK
    Can J Physiol Pharmacol; 1999 May; 77(5):330-8. PubMed ID: 10535682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000.
    Smolka AJ; Goldenring JR; Gupta S; Hammond CE
    BMC Gastroenterol; 2004 Feb; 4():4. PubMed ID: 15028114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB).
    Arikawa Y; Nishida H; Kurasawa O; Hasuoka A; Hirase K; Inatomi N; Hori Y; Matsukawa J; Imanishi A; Kondo M; Tarui N; Hamada T; Takagi T; Takeuchi T; Kajino M
    J Med Chem; 2012 May; 55(9):4446-56. PubMed ID: 22512618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
    Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
    Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
    Andersson K; Carlsson E
    Pharmacol Ther; 2005 Dec; 108(3):294-307. PubMed ID: 16000224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of salvianolic acid A, a depside from roots of Salvia miltiorrhiza, on gastric H+,K(+)-ATPase.
    Murakami S; Kijima H; Isobe Y; Muramatsu M; Aihara H; Otomo S; Li LN; Ai CB
    Planta Med; 1990 Aug; 56(4):360-3. PubMed ID: 2173008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of acid pump antagonists (reversible PPIs).
    Wurst W; Hartmann M
    Yale J Biol Med; 1996; 69(3):233-43. PubMed ID: 9165692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Morinda citrifolia aqueous fruit extract and its biomarker scopoletin on reflux esophagitis and gastric ulcer in rats.
    Mahattanadul S; Ridtitid W; Nima S; Phdoongsombut N; Ratanasuwon P; Kasiwong S
    J Ethnopharmacol; 2011 Mar; 134(2):243-50. PubMed ID: 21163341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gastric acid secretion by a standardized aqueous extract of Cecropia glaziovii Sneth and underlying mechanism.
    Souccar C; Cysneiros RM; Tanae MM; Torres LM; Lima-Landman MT; Lapa AJ
    Phytomedicine; 2008 Jun; 15(6-7):462-9. PubMed ID: 18462931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of gastric H+, K(+)-ATPase and acid secretion by ellagic acid.
    Murakami S; Isobe Y; Kijima H; Nagai H; Muramatu M; Otomo S
    Planta Med; 1991 Aug; 57(4):305-8. PubMed ID: 1663631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.